glp 1 sleep apnea How to Treat Moderate With New GLP-1 Medications The pleiotropic effects of glucagon-like
Description
In short, DPP-4 removes two N-terminal amino acids from natural peptides positioned in the penultimate (S 1 ) site, such as proline or alanine, thus inactivating GLP-1 and GIP
Am J Physiol Endocrinol Metab (2012) 303(2):E26571
Make sure that the patient understands and complies with the guidelines regarding diet habits (Table 2, Figure 1 and Figure 2)
doi: 10.1007/s11883-022-01041-7
For example, if the main issue for the patient is postprandial hyperglycemia, and fasting glucoses are near normal, an agent, such as nateglinide, that has a limited effect on the fasting glucose would be ideal
